Implantable cardioverter-defibrillators (ICDs) reduce mortality in patients at risk of sudden
cardiac death. 1–3 Transvenous lead-related complications 4–6 have prompted the …

Objectives The aim of this study was to evaluate the safety and performance of an
extravascular (EV) implantable cardioverter-defibrillator (ICD). Background Limitations of …

Abstract Background The investigational Extravascular Implantable Cardioverter Defibrillator
(EV ICD) is an implantable defibrillator with defibrillation and pacing therapies, including the …

Aims The aim of this study is to provide a thorough, quantified assessment of the substernal
space as the site of extravascular implantable cardioverter-defibrillator (ICD) lead placement …

Introduction The extravascular implantable cardioverter‐defibrillator (EV ICD) system with
substernal lead placement is a novel nontransvenous alternative to current commercially …

Over the course of several decades, the transvenous implantable cardioverter-defibrillator
(TV-ICD) has grown to become a safe and effective treatment for the prevention of sudden …

Background The extravascular implantable cardioverter–defibrillator (ICD) has a single lead
implanted substernally to enable pause-prevention pacing, antitachycardia pacing, and …

Implantable cardioverter-defibrillators (ICDs) have demonstrated remarkable effectiveness
in preventing sudden cardiac death in patients who are at high risk of ventricular …

Background Implantable cardioverter–defibrillators (ICDs) prevent sudden death from
cardiac causes in selected patients but require the use of transvenous lead systems. To …

The subcutaneous implantable cardioverterdefibrillator (S-ICD) was developed in response
to endovascular lead complications with traditional transvenous implantable cardioverter …